Skip to main content
Ondine Biomedical Inc. logo

Ondine Biomedical Inc. — Investor Relations & Filings

Ticker · OBI ISIN · CA68234M2058 LEI · 9845005B69E07CGF4A56 TSXV Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2022-06-08 Declaration of Voting R…
Country CA Canada
Listing TSXV OBI

About Ondine Biomedical Inc.

https://ondinebio.com/

Ondine Biomedical Inc. is a life sciences company that develops and commercializes photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by drug-resistant pathogens. The company's patented platform technology involves applying a photosensitive agent to a targeted area, followed by illumination with non-thermal laser light. This process creates an oxidative burst that rapidly destroys pathogens like bacteria, viruses, and fungi without inducing microbial resistance. Its lead product, Steriwave™, is a nasal decolonization therapy used to eradicate pathogens in the nasal cavity, primarily to reduce the risk of healthcare-associated infections (HAIs) such as post-operative surgical site infections. The company's product pipeline is exploring applications for chronic rhinosinusitis, burns, wounds, and ventilator-associated pneumonia.

Recent filings

Filing Released Lang Actions
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement (under 5,000 characters) from Ondine Biomedical Inc. titled 'Result of AGM'. It explicitly states that all resolutions at the Annual General Meeting held on 7 June 2022 were passed. This fits the definition of a Declaration of Voting Results (DVA).
2022-06-08 English
Posting of annual report
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) from Ondine Biomedical Inc. stating that their Annual Report for the year ended 31 December 2021 has been posted and is available on their website. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, and therefore qualifies as a Report Publication Announcement (RPA).
2022-06-07 English
Full Year Results to 31 December 2021
Earnings Release Classification · 95% confidence The document is an 'Earnings Release' (ER) from Ondine Biomedical Inc. It contains the company's financial highlights, operational highlights, and statements from the Chairman and CEO regarding the fiscal year ended 31 December 2021. While it mentions that a full Annual Report will be published later, the document itself serves as the initial announcement of the audited annual results, which fits the definition of an Earnings Release. FY 2021
2022-05-19 English
Notice of AGM
AGM Information Classification · 98% confidence The document is a short announcement (under 5,000 characters) from Ondine Biomedical Inc. regarding the scheduling and virtual format of their upcoming Annual General Meeting (AGM). It directs readers to the company website to access the actual notice of the AGM. According to the 'Menu vs Meal' rule, since this is an announcement about the availability of a report/notice rather than the document itself, it is classified as a Report Publication Announcement (RPA).
2022-05-17 English
WHO calls for better infection prevention
Regulatory Filings Classification · 95% confidence The document is a press release distributed via the 'Reach' service of the London Stock Exchange (RNS). It discusses a company's (Ondine Biomedical Inc.) technology in the context of a recent World Health Organization report on infection prevention. It does not contain financial results, regulatory filings, or specific corporate actions like dividends or board changes. As it is a general corporate announcement that does not fit into specific financial reporting categories, it is classified as a Regulatory Filing (RNS).
2022-05-10 English
Appointment of Nominated Adviser
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from the London Stock Exchange regarding the appointment of a new Nominated Adviser (Nomad) for Ondine Biomedical Inc. This type of corporate announcement regarding advisory appointments or changes in professional representation does not fit into specific categories like M&A, financial reports, or director dealings. Therefore, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2022-04-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.